Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Malaria, Falciparum D016778 22 associated lipids
Endometrial Neoplasms D016889 30 associated lipids
Gram-Negative Bacterial Infections D016905 16 associated lipids
Colitis, Ischemic D017091 3 associated lipids
Liver Failure D017093 5 associated lipids
Tachycardia, Ventricular D017180 9 associated lipids
Strongylida Infections D017206 5 associated lipids
Hypertrophy, Right Ventricular D017380 4 associated lipids
Dermatitis, Allergic Contact D017449 20 associated lipids
Soft Tissue Injuries D017695 2 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Abu-Zidan FM et al. Role of platelet-activating factor on cardiovascular dysfunction in postischemic shock in pigs. 1997 Eur Surg Res pmid:9058081
Yousefi S et al. Platelet-activating factor and the production of human interferon-gamma. 1997 J. Interferon Cytokine Res. pmid:9058317
Bussolino F et al. Role of soluble mediators in angiogenesis. 1996 Eur. J. Cancer pmid:9059328
Lee YP et al. Analysis of human lecithin-cholesterol acyltransferase activity by carboxyl-terminal truncation. 1997 Biochim. Biophys. Acta pmid:9059515
Ohkuni H et al. Purification and partial characterization of a novel human platelet aggregation factor in the extracellular products of Streptococcus mitis, strain Nm-65. 1997 FEMS Immunol. Med. Microbiol. pmid:9061358
Nick JA et al. Common and distinct intracellular signaling pathways in human neutrophils utilized by platelet activating factor and FMLP. 1997 J. Clin. Invest. pmid:9062356
Becker BF et al. [Interaction of adenosine with leukocytes and thrombocytes]. 1996 Z Kardiol pmid:9064961
Ishii I et al. Alanine exchanges of polar amino acids in the transmembrane domains of a platelet-activating factor receptor generate both constitutively active and inactive mutants. 1997 J. Biol. Chem. pmid:9065450
Odawara M et al. Ginkgo biloba. 1997 Neurology pmid:9065574
Bauldry SA and Wooten RE Induction of cytosolic phospholipase A2 activity by phosphatidic acid and diglycerides in permeabilized human neutrophils: interrelationship between phospholipases D and A2. 1997 Biochem. J. pmid:9065750
Wang H et al. Regulation of platelet-activating factor receptor gene expression in vivo by endotoxin, platelet-activating factor and endogenous tumour necrosis factor. 1997 Biochem. J. pmid:9065783
Kagoshima M et al. Effects of Y-24180, a long-acting and potent antagonist to platelet-activating factor, on immediate asthmatic response in guinea pigs. 1997 Pharmacology pmid:9065955
Gomez R et al. Pathogenesis of preterm labor and preterm premature rupture of membranes associated with intraamniotic infection. 1997 Infect. Dis. Clin. North Am. pmid:9067790
Tamura T et al. Effects of platelet-activating factor on left ventricular performance in dogs. 1997 Jpn. Circ. J. pmid:9070974
Mineshita M et al. Whole-blood incubation method to study neutrophil cytoskeletal dynamics. 1997 J. Immunol. Methods pmid:9075772
Mori TA et al. Interactions between dietary fat, fish, and fish oils and their effects on platelet function in men at risk of cardiovascular disease. 1997 Arterioscler. Thromb. Vasc. Biol. pmid:9081682
Kume K et al. [Study of platelet activating factor by using mouse ontogenic technology]. 1996 Nihon Rinsho Meneki Gakkai Kaishi pmid:9081720
Kurose I et al. Oxidative stress during platelet-activating factor-induced microvascular dysfunction. 1996 Microcirculation pmid:9086452
Lin CC and Lin CY Bronchoconstriction and eosinophil recruitment in guinea pig lungs after platelet activating factor administration. 1997 J Asthma pmid:9088302
Yatsu T et al. Renal effect of YM435, a new dopamine D1 receptor agonist, in anesthetized dogs. 1997 Eur. J. Pharmacol. pmid:9088869
Byrum RS et al. Role of the 5-lipoxygenase-activating protein (FLAP) in murine acute inflammatory responses. 1997 J. Exp. Med. pmid:9091580
Matsubara T et al. Platelet-activating factor (PAF) and PAF acetylhydrolase activity in rat uterus and placenta during the late stages of pregnancy. 1997 Biol. Reprod. pmid:9096869
Rocha FA et al. PAF modulates eicosanoids and TNF release in immune-complex arthritis in rats. 1997 J Lipid Mediat Cell Signal pmid:9101418
Kudolo GB et al. Chronic hyperinsulinemia inhibits platelet-activating factor (PAF) biosynthesis in the rat kidney. 1997 J Lipid Mediat Cell Signal pmid:9101420
Denizot Y et al. Presence and metabolism of lyso platelet-activating factor in human bone marrow. 1997 J Lipid Mediat Cell Signal pmid:9101422
Mollinedo F et al. Selective induction of apoptosis in cancer cells by the ether lipid ET-18-OCH3 (Edelfosine): molecular structure requirements, cellular uptake, and protection by Bcl-2 and Bcl-X(L). 1997 Cancer Res. pmid:9102220
Toledano BJ et al. Platelet-activating factor abrogates apoptosis induced by cross-linking of the surface IgM receptor in a human B lymphoblastoid cell line. 1997 J. Immunol. pmid:9103434
Norman KE et al. Comparison of the reversed passive Arthus and local Shwartzman reactions of rabbit skin: effects of the long-acting PAF antagonist UK-74,505. 1997 Br. J. Pharmacol. pmid:9105704
Takano H et al. Effects of aminoguanidine on systemic inflammatory response syndrome induced by platelet activating factor and by lipopolysaccharide in rats. 1997 Eur. J. Pharmacol. pmid:9105885
Silverstein FS et al. Cytokines and perinatal brain injury. 1997 Apr-May Neurochem. Int. pmid:9106251
Baker RR and Chang HY Neuronal nuclear acetyltransferases involved in the synthesis of platelet-activating factor are located in the nuclear envelope and show differential losses in activity. 1997 Biochim. Biophys. Acta pmid:9106499
Konstantinov SM et al. Efficacy of anticancer alkylphosphocholines in Trypanosoma brucei subspecies. 1997 Acta Trop. pmid:9107362
Guerrant RL et al. Diarrhea, demography and cell signaling: lessons from microbial toxins. 1997 Trans. Am. Clin. Climatol. Assoc. pmid:9108674
Thielman NM et al. Role of platelet-activating factor in Chinese hamster ovary cell responses to cholera toxin. 1997 J. Clin. Invest. pmid:9109445
Nishiwaki H et al. Prednisolone, platelet-activating factor receptor antagonist, or superoxide dismutase reduced leukocyte entrapment induced by interferon alpha in retinal microcirculation. 1997 Invest. Ophthalmol. Vis. Sci. pmid:9112975
Gentry PA et al. An inherited platelet function defect in a Simmental crossbred herd. 1997 Can. J. Vet. Res. pmid:9114964
Ali H et al. Role of phospholipase Cbeta3 phosphorylation in the desensitization of cellular responses to platelet-activating factor. 1997 J. Biol. Chem. pmid:9115222
Nauck M et al. Induction of vascular endothelial growth factor by platelet-activating factor and platelet-derived growth factor is downregulated by corticosteroids. 1997 Am. J. Respir. Cell Mol. Biol. pmid:9115750
Okada S et al. Transmigration of eosinophils through basement membrane components in vitro: synergistic effects of platelet-activating factor and eosinophil-active cytokines. 1997 Am. J. Respir. Cell Mol. Biol. pmid:9115757
Greaves MW and Judge MR Platelet activating factor in psoriasis. 1997 Br. J. Dermatol. pmid:9115938
Muguruma K and Johnston JM Metabolism of platelet-activating factor in rat epididymal spermatozoa. 1997 Biol. Reprod. pmid:9116157
Le Solleu H et al. Determination of a PAF antagonist pharmacophore using combined Molecular Electrostatic Potential and Molecular Lipophilicity Potential. 1994 Drug Des Discov pmid:9116169
Miao FJ et al. Contribution of adrenal hormones to nicotine-induced inhibition of synovial plasma extravasation in the rat. 1997 Br. J. Pharmacol. pmid:9117123
Im SY et al. A protective role of platelet-activating factor in murine candidiasis. 1997 Infect. Immun. pmid:9119469
Milella M et al. CD16 cross-linking induces both secretory and extracellular signal-regulated kinase (ERK)-dependent cytosolic phospholipase A2 (PLA2) activity in human natural killer cells: involvement of ERK, but not PLA2, in CD16-triggered granule exocytosis. 1997 J. Immunol. pmid:9120268
Xia D and Samols D Transgenic mice expressing rabbit C-reactive protein are resistant to endotoxemia. 1997 Proc. Natl. Acad. Sci. U.S.A. pmid:9122237
Keskinoglu A et al. Inflammatory lipid mediators and immunologic recognition in allogeneic renal transplantation. 1997 Feb-Mar Transplant. Proc. pmid:9122948
Owen CA et al. Cytokines regulate membrane-bound leukocyte elastase on neutrophils: a novel mechanism for effector activity. 1997 Am. J. Physiol. pmid:9124593
Teixeira MM and Hellewell PG Evidence that the eosinophil is a cellular target for the inhibitory action of salmeterol on eosinophil recruitment in vivo. 1997 Eur. J. Pharmacol. pmid:9128847
He CF et al. Postural vasoregulation and mediators of reperfusion injury in venous ulceration. 1997 J. Vasc. Surg. pmid:9129619